// App-Quantinova.ai

4577 : Fibroblast growth factor receptor-4 (FGFR-4) as a novel therapeutic target for pancreatic cancer

Researchers

Presenter

  • Toshiyuki Ishiwata

Principal Investigators

  • Hisashi Yoshimura

  • Yoko Matsuda

  • Shunji Ishiwata

Medical Centers

  • Nippon Medical School, Tokyo, Japan

  • Nippon Veterinary and Life Science University, Tokyo, Japan.

  • Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Japan

  • Kinki University, Osaka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Pancreas ductal adenocarcinoma

  • Squamous cell carcinoma of the head and neck

  • Soft tissue sarcoma

  • Pancreatic cancer

  • Ovarian cancer

  • Breast cancer

  • Solid malignancies

  • Sarcoma

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • Arginine hydrochloride

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved